Analytical and semipreparative high performance liquid chromatography separation of stereoisomers of novel 3,4-dihydropyrimidin-4(3H)-one derivatives on the immobilised amylose-based Chiralpak IA chiral stationary phase.

Direct HPLC separation of stereoisomers of three novel 5-methyl-2-(alkylthio)-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones endowed with antiviral and potential antiproliferative and morphological differentiation activity against melanoma cells was performed by using the new immobilised amylose-based Chiralpak IA chiral stationary phase. Stereoselective conditions were achieved using normal phase eluents containing "non-standard" solvents such as ethyl acetate, methyl tertbutyl ether, or dichloromethane. In order to study the chiroptical properties of single stereoisomers, mg-scale separations were performed on analytical and semipreparative size Chiralpak IA columns in combination with ethyl acetate-based eluents.